{
  "trial_id": "NCT00473460",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "Male or female out-patients >/= 45 years",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Subjects suffering from chronic bronchitis",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "FEV1</= 70% and FEV1/FVC </= 70% predicted from age, height and sex",
      "label": "unknown",
      "evidence": "quote: Hgb: 8 g/dl, WBC: 10000 /mm3, Plt: 300000 /ml"
    },
    {
      "criterion": "No documented episode of AECB (requiring treatment) within 6 weeks of randomization",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Sputum production on most days, even when exacerbation free",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "Subjects presented with at least two documented (i.e. requiring antibiotics and/or systemic steroid administration) acute exacerbation episodes during the last 12 months",
      "label": "unknown",
      "evidence": "quote: The patient has had positive history of sickle cell crises since childhood."
    },
    {
      "criterion": "If receiving chronic therapy with inhaled long acting bronchodilators and/or inhaled or systemic steroids, the treatment must have remained stable for the preceding 6 weeks prior to screening",
      "label": "unknown",
      "evidence": "quote: He also had the same symptoms in past two weeks treated with oxycodone which was not beneficial to his pain."
    },
    {
      "criterion": "Smoking history of at least 20 pack-years",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "Subjects willing and able to give fully informed written consent",
      "label": "met",
      "evidence": "unknown"
    }
  ],
  "exclusion": [
    {
      "criterion": "Known bronchial carcinoma, pulmonary tuberculosis, cystic fibrosis, documented chronic bronchial asthma or diffuse bronchiectasis",
      "label": "triggers",
      "evidence": "none"
    },
    {
      "criterion": "Subjects who are actively participating in intensive pulmonary rehabilitation programs",
      "label": "unknown",
      "evidence": "quote: He won't smoke or uses any illicit drugs."
    },
    {
      "criterion": "Subjects with a known history of chronic colonization of pathogenic organisms resistant to moxifloxacin, e.g. Pseudomonas spp, MRSA",
      "label": "unknown",
      "evidence": "quote: No splenomegaly was detected in the physical exam."
    },
    {
      "criterion": "No systemic or inhaled antibiotic therapy during the 6 weeks prior to screening and any long term antibiotic usage",
      "label": "triggers",
      "evidence": "none"
    },
    {
      "criterion": "Subjects requiring home ventilatory support for COPD and those who have a tracheostomy in situ (subjects requiring home/potable oxygen therapy or CPAP for sleep apnea can be included)",
      "label": "unknown",
      "evidence": "quote: The patient is afebrile within the normal blood pressure."
    }
  ],
  "notes": "The patient has had positive history of sickle cell crises since childhood. He also had the same symptoms in past two weeks treated with oxycodone which was not beneficial to his pain.",
  "_meta": {
    "topic_id": "45",
    "trial_id": "NCT00473460",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}